Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | November 17, 2006 | ||||
Last Updated Date | March 7, 2008 | ||||
Start Date † | September 2002 | ||||
Current Primary Outcome Measures † |
|
||||
Original Primary Outcome Measures † |
|
||||
Change History | Complete list of historical versions of study NCT00401648 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
|
||||
Original Secondary Outcome Measures † |
|
||||
Descriptive Information | |||||
Brief Title † | Effect of Brivaracetam in Photosensitive Epileptic Subjects | ||||
Official Title † | A Placebo-Controlled, Single-Blind, Multi-Center Study to Explore the Photoparoxysmal Response in Photosensitive Epileptic Subjects After One Single Oral Dose of Brivaracetam in Capsules. | ||||
Brief Summary | to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects |
||||
Detailed Description | |||||
Study Phase | Phase II | ||||
Study Type † | Interventional | ||||
Study Design † | Treatment, Non-Randomized, Single Blind, Placebo Control, Single Group Assignment | ||||
Condition † | Epilepsy | ||||
Intervention † | Drug: Brivaracetam | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Completed | ||||
Enrollment † | 20 | ||||
Completion Date | June 2003 | ||||
Primary Completion Date | June 2003 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 18 Years to 60 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† | |||||
Location Countries † | France, Germany | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00401648 | ||||
Responsible Party | |||||
Secondary IDs †† | Protocol Number RPCE02D2304 | ||||
Study Sponsor † | UCB | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | UCB | ||||
Verification Date | March 2008 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |